Nextgen Healthcare Inc - NXGN STOCK NEWS

NextGen Healthcare (NASDAQ: NXGN) partners with Validic to enhance patient care through real-time remote patient monitoring (RPM). White House Clinics in Kentucky, utilizing NextGen's integrated digital health platform, leverages RPM for chronic-condition management, improving patient engagement and care insights. The solution streamlines data from various devices, facilitating better clinical decision-making. NextGen's technology suite includes EHR, practice management, and patient experience tools, enabling comprehensive healthcare delivery.

NextGen Healthcare, Inc. (NASDAQ: NXGN) will host its 24th annual User Group Meeting (UGM) virtually from November 8-10, 2021. The event, themed “Engage,” aims to provide insights and trends affecting ambulatory practices. Keynote presentations will be delivered by Marty Makary, a prominent health policy expert, and Paralympic star Amy Purdy. The UGM will feature 20 discussion forums, 1:1 meetings with experts, and opportunities for CME and CNE credits. Registration is open, with rates set at $499 for individuals and $3,499 for groups.

NextGen Healthcare, Inc. (NASDAQ: NXGN) will release its fiscal 2022 Q2 operating results on October 28, 2021, post-market. A conference call will follow at 5:00 p.m. ET, where shareholders can join via phone. This quarterly result marks an important update for investors, reflecting the company's performance in the ambulatory technology sector.

NextGen is a leader in providing technology solutions for ambulatory care, focusing on improving clinical productivity and financial outcomes.

NextGen Healthcare, Inc. (NASDAQ: NXGN) held its 2021 Annual Meeting, where founder Sheldon Razin expressed gratitude towards shareholders for their engagement. He highlighted the company's growth and market expansion, crediting the dedication of the team and the recent appointment of new CEO David Sides. Razin emphasized that NextGen Healthcare is well-positioned to continue its leadership in the ambulatory care market, supported by its impressive portfolio of products and services.

NextGen Healthcare, Inc. (Nasdaq: NXGN) announced significant outcomes from its Annual Meeting. Shareholders approved the company's reincorporation into Delaware, eliminated cumulative voting in director elections, and elected all nine director nominees. The Board now includes eight independent directors and a new CEO, enhancing diversity and expertise. Additionally, shareholders ratified the appointment of the accounting firm and amended the equity plan. However, proposals regarding executive compensation and Board authority increase were not approved. Results will be filed with the SEC.

NextGen Healthcare, Inc. (NASDAQ: NXGN) has partnered with the Community Health Center of Snohomish County in Washington to implement its comprehensive technology solutions. The adoption includes NextGen Enterprise EHR, PM, and Population Health solutions to enhance healthcare services for nearly 70,000 annual patients. The clinic aims to improve productivity, simplify billing, and expand access to care, especially for underserved populations. The integrated platform supports complex healthcare requirements, enabling the clinic to enhance patient engagement and service delivery.

NextGen Healthcare (NXGN) encourages shareholders to vote 'FOR' its nominated directors and proposals on the WHITE proxy card for the upcoming Annual Meeting on October 13, 2021. The company has received endorsements from three prominent proxy advisory firms: ISS, Glass Lewis, and Egan-Jones. The Board highlights significant transformations under new leadership, emphasizing enhanced capital allocation towards R&D and strategic M&A, resulting in an improved management team and boosted employee engagement. The firm reports accelerating revenue growth and strong operating cash flow with no debt.

NextGen Healthcare, Inc. (Nasdaq: NXGN) has expanded its collaboration with Mednax, Inc., enhancing its integrated healthcare platform. Mednax will now utilize NextGen Virtual Visits™ and NextGen® Mobile to streamline patient care. This integration supports over 800 ambulatory providers across 39 states, facilitating efficient workflows and improving patient experiences.

The Razin Group, representing 15.2% of NextGen Healthcare (NXGN) shares, advocates for the election of a new board slate during the Annual Meeting on October 13, 2021. The group criticizes the current board's six years of underperformance under Chairman Jeffrey Margolis, noting a lack of significant growth despite repeated promises. They urge shareholders to vote on the BLUE Proxy Card to reset the board's power dynamics, emphasizing the importance of board members having meaningful equity stakes for accountability and better governance.